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Abstract 
Cell labeling and tracking are important processes in understanding biologic mechanisms and the 
therapeutic effect of inoculated cells in vivo. Numerous attempts have been made to label and track 
inoculated cells in vivo; however, these methods have limitations as a result of their biological ef-
fects, including secondary phagocytosis of macrophages and genetic modification. Here, we in-
vestigated a new cell labeling and tracking strategy based on metabolic glycoengineering and 
bioorthogonal click chemistry. We first treated cells with tetra-acetylated 
N-azidoacetyl-D-mannosamine to generate unnatural sialic acids with azide groups on the surface 
of the target cells. The azide-labeled cells were then transplanted to mouse liver, and dibenzyl 
cyclooctyne-conjugated Cy5 (DBCO-Cy5) was intravenously injected into mice to chemically bind 
with the azide groups on the surface of the target cells in vivo for target cell visualization. Unnatural 
sialic acids with azide groups could be artificially induced on the surface of target cells by gly-
coengineering. We then tracked the azide groups on the surface of the cells by DBCO-Cy5 in vivo 
using bioorthogonal click chemistry. Importantly, labeling efficacy was enhanced and false signals by 
phagocytosis of macrophages were reduced. This strategy will be highly useful for cell labeling and 
tracking. 
Key words: cell labeling, cell tracking, metabolic glycoengineering, click chemistry, chemical re-
porter. 
Introduction 
Cell labeling and tracking are important pro-
cesses in understanding biologic mechanisms and the 
therapeutic effect of inoculated cells in vivo. Cell la-
beling and tracking can be used to distinguish trans-
planted cells from host cells, monitor distribution and 
migration after transplantation, and evaluate func-
tional effects of the transplanted cells. Indeed, nu-
merous approaches have been developed for the vis-
ualization of cells of interest in vivo [1-10]. Typical 
labeling and tracking methods are used to label target 
cells directly or indirectly [2, 5]. For direct labeling 
and tracking, various agents, including fluorescent 
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probes, super-paramagnetic iron oxide, and radio-
tracers, have been utilized [1-10]. Basically, the target 
cells are labeled with these probes prior to transplan-
tation, and are visualized with suitable imaging 
equipment. Although these probes enable easy visu-
alization of transplanted cells in vivo, cell tracking has 
significant limitations by biological effects [10, 11]. 
Dead cells and released imaging probes may be sec-
ondarily phagocytized by host macrophages [11]. 
Thus, it is not clear whether the imaging signal comes 
from targeted cells or from macrophages. In order to 
overcome the disadvantage of direct labeling, genetic 
modifications have been used as an indirect labeling 
and tracking method for the expression of extrinsic 
genes [12-15]. However, genetic modifications using 
nonviral and viral systems have disadvantages, such 
as difficulties in controlling gene expression and the 
possibility of tumor formation [16, 17]. Therefore, de-
vising an appropriate labeling and tracking method 
that can overcome these limitations is critical for un-
derstanding biologic mechanisms and therapeutic 
effects in vivo. 
Mounting evidence has shown that glycan met-
abolic labeling can be visualized by chemical ligation 
with a fluorescent probe, as the glycan metabolic la-
beling can outfit living cells with a bioorthogonal 
chemical reporter for cellular imaging [18-22]. In par-
ticular, unnatural analogs of N-acetyl mannosamine is 
metabolized by cultured cells and converted to azido 
sialic acid on the surface of various cells without any 
apparent physiological harm [23]. Azide groups on 
the cell surface have been treated with dibenzyl cy-
clooctyne (DBCO)-labeled fluorescent probes for cel-
lular imaging [20, 22, 24]; however, these studies were 
not focused on the tracking of specific cells in vivo. In 
fact, no studies have demonstrated this reaction for 
tracking of specific cells in vivo. When applied in cell 
labeling and tracking, this method can overcome the 
limitations by biological effects because a reaction is 
not normally found in biological systems. In addition, 
this reaction is rapid, selective, and produces high 
yields. Thus, this may result in low background and 
high sensitivity without signal transfer and difficul-
ties in controlling extrinsic gene expression when 
used for the detection of specific cells in vivo. 
To that end, we introduce a new in vivo tracking 
strategy of target cells via bioorthogonal chemical 
reporters (Scheme 1/Figure A). We first treated cells 
with tetra-acetylated N-azidoacetyl-D-mannosamine 
(Ac4ManNAz) to generate unnatural sialic acids with 
azide groups on the surface of the target cells. The 
azide-labeled cells were then transplanted to the liver 
of mouse, and DBCO-conjugated Cy5 (DBCO-Cy5) 
was intravenously injected into mice to chemically 
bind with the azide groups on 
the surface of the target cells in 
vivo for visualization of the 
target cells. 
 
 
 
 
 
 
Figure A. (Scheme 1) Schematic illus-
tration of cell labeling and tracking via 
bioorthogonal chemical reporters. 
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Results and Discussion 
To generate azide groups on the surface of the 
target cells (A549 cells), cells were treated with 
Ac4ManNAz, which readily results in unnatural sialic 
acids on the cell surface [25-28]. Generation of the 
azide groups on the targeted cell surface was deter-
mined by successful binding with DBCO-Cy5. After 
treatment with DBCO-Cy5, cells treated with 
Ac4ManNAz were stained with Cy5 and showed 
higher fluorescence intensity than that of untreated 
cells (Figure 1A and B). Coomassie blue staining and 
western blot analysis also revealed the generation of 
azide groups on target cells after treatment with 
Ac4ManNAz (Figure 1C). We also performed azide 
group labeling by treatment with Ac4ManNAz on 
various cell types (KB, A549, U87MG, MCF-7, 
MDA-MB-468, and MDA-MB-436). As expected, the 
azide groups were generated on all cell types by gly-
can metabolic engineering, which could bind with 
DBCO-Cy5. All cell types treated with Ac4ManNAz 
were positive for Cy5 after treatment with DBCO-Cy5 
(Supplementary Material: Figure S1). Azide groups 
formed on the cell surface can be shed from cell sur-
faces and endocytosed or recycled by neighboring 
cells. Thus, to verify that a majority of the glycan sig-
nal remains localized to the A549 cells, independent 
labeling using GFP-labeled A549 cells was performed. 
In co-culture with GFP-labeled A549 and N3-labeled 
A549 cells, N3-labeled A549 cells were stained with 
Cy5 and GFP-labeled A549 cells were not stained with 
Cy5 after treatment of DBCO-Cy5 (Figure 1D). These 
results indicate that azide groups were successfully 
formed on the surface of the target cells. The az-
ide-labeled cells by glycan metabolic engineering 
would provide a new targeting characteristic using 
bioorthogonal click chemistry.  
The azide groups on the cell surface were re-
tained for 3 days in vitro. N3-labeled cells were re-
acted immediately with DBCO-Cy5 at each time 
point. After treatment with DBCO-Cy5, N3-labeled 
cells were stained with Cy5 and showed higher fluo-
rescence intensity than that of untreated cells (Figure 
2A and B). In addition, the azide groups on the cell 
surface were also retained in vivo for 3 days after 
transplantation (Figure 2C). These results indicate 
that artificially introduced azide groups on the cell 
surface can be targeted by DBCO-Cy5 for more than 3 
days after treatment with Ac4ManNAz. 
 
 
Figure 1. Introduction of unnatural sialic acids with azide groups on the cell surface. (A) Visualization of azide groups on the surface of tetra-acetylated 
N-azidoacetyl-D-mannosamine (Ac4ManNAz)-treated cells (n = 5). (B) Flow cytometry analysis of (A) (n = 3). (C) Coomassie staining and western blot 
analysis of Ac4ManNAz-treated cells showing the amount of total proteins and generated azide groups (n = 5). (D) Visualization of azide groups on the cell 
surface in co-culture of azide labeled cells and azide-unlabeled cells (GFP-positive A549 cells). The scale bars indicate 50 µm in A and 100 µm in D.  
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Figure 2. Visualization of retained azide groups on the cell surface in vitro and in vivo. (A) Visualization of retained azide groups on the cell surface in vitro 
(n = 5). (B) Flow cytometry analysis of (A) (n = 3). (C) Visualization of retained azide groups on the cell surface in vivo. The scale bars indicate 50 µm in A 
and 100 µm in C.  
 
In this study, we used Ac4ManNAz to induce 
azide groups on the cell surface and DBCO to target 
unnatural azide groups on the surface of cells because 
of its high reactivity and low toxicity [22, 29-32]. Re-
cent reports have revealed that these reactions rapidly 
proceed in aqueous media at biocompatible pH and 
temperature and can be applied to live cells and or-
gans in vivo [33]. Ideal labeling and tracking method 
should be non-cytotoxic and not have harmful effects 
on other cellular function. In this study, Ac4ManNAz 
showed low cytotoxicity at various concentrations for 
A549 cells (Figure 3A). In addition, the cytotoxicity of 
DBCO, as measured with MTT assay, was not in-
creased at high concentration (100 µM) over culture 
time (Figure 3B). For systemic toxicity of DBCO, the 
DBCO (25 µM, 200 µL) was injected into tail vein of 
the normal mice. To evaluate systemic toxicity of 
DBCO injection, survival rate and behavioral changes 
were carefully monitored in the mice. All mice (n = 5) 
were survived after one day and any particular be-
havioral abnormalities were not noticed in any mouse 
treated with DBCO and control group. In the histo-
logic examination, discernible hemorrhage, infarction, 
or wide range of apoptosis was not observed in any of 
the visceral organs including kidney, liver, spleen, 
and lung of DBCO treated mice (Figure 3C). Taken 
together, no apparent symptoms and histological le-
sions for severe systemic toxicity of DBCO were ap-
peared in the mice. 
Compared to traditional direct and indirect 
tracking methods, our strategy has several ad-
vantages. First, our system is more consistent and 
effective than that of the traditional direct and indirect 
labeling method. We selected DiD labeling as a con-
trol for traditional direct labeling method because 
DiD labeling have proven effective for in vitro cell 
labeling with optical imaging and they bind to the cell 
membrane, like an our system. Both types labeling 
showed higher florescence intensity than that of un-
treated cells (Figure 4B and C). However, DiD showed 
higher cytotoxicity than DBCO at various concentra-
tions (Figure 4A). Labeling efficacy of our system was 
also compared with genetic modification using en-
hanced green fluorescence protein (EGFP) gene 
transfection by lipofectamineTM2000 (Lipo2k) and 
branched polyethylenimine (BPEI) to avoid the po-
tential risks associated with a viral vector as an indi-
rect labeling method. EGFP gene transfection resulted 
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in 51.1 and 37.1% EGFP expression (Figure 4D). In 
contrast, our system showed 100% label efficacy. The 
efficiency of indirect label methods using genetic 
modification is highly variable depending on the 
availability of specialized equipment and the skills of 
the technicians. In addition, the amount of bound 
DBCO-Cy5 on the cell surface increased with 
DBCO-Cy5 concentration (Figure 4B), indicating that 
the degree of labeling can be controlled by changing 
the concentration of DBCO-Cy5 in a dose-dependent 
manner. 
Second, our system may reduce distorted signals 
by phagocytosis of host macrophages in vivo. To ex-
amine distorted signals, we used a co-culture system. 
Prior to co-culture, apoptosis of target cells was in-
duced with staurosporine [34-36] this was followed by 
culturing apoptotic cells with macrophages. After 
co-culture, macrophages were treated with 
DBCO-Cy5 to determine the generation of azide 
groups by phagocytosis of apoptotic cells. As the 
control group, target cells were fluorescently labeled 
with a direct label agent (DiD) prior to the induction 
of apoptosis. For detection of macrophages, macro-
phages were stained for F4/80, a macrophage-specific 
marker. As expected, macrophages were negative for 
DBCO-Cy5. In contrast, 38% of macrophages were 
positive for the DiD label in the control group (Figure 
5A, B and C). In addition, we showed staining of 
macrophages directly in the liver section to determine 
false positive signals by macrophages (Figure 5D). For 
detection of macrophages in the liver section, mac-
rophages were stained for F4/80 after treatment of 
DBCO-Cy5. As expected, macrophages were negative 
for DBCO-Cy5 in N3-labeled A549 treatment group. In 
contrast, positive macrophages for DiD were found in 
DiD-labeled A549 treatment group. These results in-
dicate that macrophages do not generate azide groups 
after phagocytosis of target cells with acquired azide 
groups. Thus, macrophages may not produce false 
signals in vivo after phagocytosis of target cells. 
 
Figure 3. Cytotoxicity of Ac4ManNAz and dibenzyl cyclooctyne (DBCO). (A) Cytotoxicity of Ac4ManNAz at various concentrations for 72 hours in vitro. 
(B) Cytotoxicity of DBCO at various concentrations for 48 hours in vitro. (C) Hematoxylin and eosin (H&E) staining of liver, lung, spleen, and kidney for 
systemic toxicity of DBCO in vivo. The experiment is expressed as mean ± SD. Data shown are representative three independent experiments. 
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Figure 4. (A) Cytotoxicity of DBCO and DiD at various concentrations in vitro. (B) Flow cytometry data of DBCO-Cy5 concentration-dependent binding 
to N3-labeled cells. (C) Flow cytometry data of DiD labeled cells at various concentration of DiD. (D) Flow cytometry data of transfected cells using 
lipofectamine and BPEI. For all experiments, data shown are representative of three independent experiments. 
 
 
To provide an assessment of the functional 
competence of cell tracking in vivo, we tracked trans-
planted cells in live mice, using an in vivo imaging 
system (IVIS) and the IV100 fluorescence imaging 
system, which has a wide range of applications, such 
as cell tracking. For in vivo tracking, the target cells 
were transplanted in the liver immediately after 
treatment with Ac4ManNAz for 3 days. For compari-
son, transplanted untreated cells served as the control. 
Three days after transplantation, DBCO-Cy5 was in-
travenously injected via the tail vein prior to tracking 
in vivo. Four hours after injection with DBCO-Cy5, a 
considerable fluorescence signal was detected in the 
liver from the azide-labeled cells and in the bladder. 
In contrast, whole body fluorescence imaging using 
IVIS indicated that DBCO-Cy5 did not affect the liver 
with azide-unlabeled cells (Figure 6A). The intrave-
nously injected DBCO may chemically bind with the 
azide groups on the surface of the target cells in vivo. 
In addition, unreacted DBCO was predominantly 
excreted through the renal route within 4 h post in-
jection and so the cell-expressing azide groups 
showed higher fluorescence intensity in the liver 
compared to liver with untreated cells or normal 
surrounding tissue. The distribution of transplanted 
cells in the liver was further evaluated by fluorescent 
image using IV100. The blood vessels were visualized 
with dextran-fluorescein isothiocyanate (FITC) 
through intravenous injection. The target 
cell-acquired azide groups were observed to surround 
a blood vessel, and the shape of target cells was simi-
lar to attached cells in culture (Figure 6B). Histology 
confirmed the presence of the target cells in the liver 
and showed that these areas contained both target 
cells and host liver cells. The target cell colonies were 
macroscopically distinguishable from the host liver 
cells as red-colored regions (Figure 6C and D).  
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Figure 5. False positive signals by macrophages in vitro and in vivo. (A) Visualization of co-cultured macrophages with DiD-labeled or N3-labeled cells (n 
= 5). (B) Flow cytometry data of co-cultured macrophages with DiD-labeled cells (n = 3). (C) Flow cytometry data of co-cultured macrophages with 
N3-labeled cells (n = 3). (D) F4/80 staining of liver sections for macrophages after transplantation of DiD-labeled or N3-labeled cells in the liver (n = 3). The 
scale bars indicate 50 µm in A and 100 µm in D. 
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Figure 6. Tracking of azide-labeled cells in the liver of mice. (A) Whole body images of mice after intravenous injection of DBCO-Cy5 (n = 8 per group). 
(B) IV100 images of liver after intravenous injection of DBCO-Cy5. The scale bars indicate 500 and 100 µm. (C) Histological staining of liver after intra-
venous injection of DBCO-Cy5. The scale bar indicates 2 mm. (D) hematoxylin and eosin staining and fluorescence image of liver after intravenous injection 
of DBCO-Cy5. The scale bar indicates 200 µm.  
 
We also evaluated the sensitivity of optical im-
aging of azide-labeled cells in the liver. The az-
ide-labeled cells (3×105, 3×104, 3×103, and 3×102 cells) 
were mixed with unlabeled cells (total cell number 
3×105 cells) and injected in the liver. Four hours post 
injection of DBCO-Cy5, livers were dissected, and 
each sample was analyzed in a Kodak imaging box. 
Histology confirmed the presence of target cells in the 
liver and demonstrated that at least 3×103 cells would 
be required for clear visualization of target cells in 
tissue (Figure 7). Single-cell sensitivity is important in 
stem cell and cancer biology field because the migra-
tion pattern of target cells is not clear after local injec-
tion and migration of cells to distant organs could 
affect therapeutics. Therefore, these results highlight 
the need for further optimization of imaging param-
eters to detect single cell in vivo. 
In this study, cell labeling and tracking method 
relies on the introduction of an unnatural azide 
groups on the cell surface. The azide labeling on the 
cell surface can readily be overexpressed by addition 
of the sugar analogs to the culture medium. Thus, we 
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were concerned that this strategy could result in 
change of biological responses of azide-labeled cells, 
including metabolism, proliferation, and migration. In 
this study, treatment of Ac4ManNAz did not affect 
viability of cells. However, several studies reported 
that sialic acid can influence the adhesive properties 
of the cell surface [37]. In addition, sialic acid can alter 
cell/cell interaction and migration [38-40]. To inves-
tigate this, experiments for change of biological re-
sponses in azide-labeled cells by metabolic glycoen-
gineering need to be performed in additional studies. 
Long-term in vivo investigation on change of biolog-
ical responses would be necessary to determine the 
clinical potential of this method.  
In conclusion, the overall results successfully 
demonstrated the potential of a new cell labeling and 
tracking strategy based on metabolic glycoengineer-
ing and bioorthogonal click chemistry. Unnatural si-
alic acids with azide groups could be artificially in-
duced on the surface of target cells by glycoengi-
neering and then effectively tracked by DBCO-Cy5 in 
vivo using bioorthogonal click chemistry. Important-
ly, labeling efficacy was enhanced and false signals 
were reduced. This strategy will be highly useful for 
cell labeling and tracking. 
 
Figure 7. Ex vivo liver tissue analysis for the sensitivity of optical imaging to cells with acquired azide groups (n = 5 per group). (A) Gross view and 
fluorescence images of liver injected with various cell concentrations. (B) The quantification data of (A). (C) Histological staining of liver injected with 
various cell concentrations. The scale bar indicates 300 µm. Symbol ** and * indicate differences at the p < 0.01 and < 0.05 significance levels, respectively 
(analyzed using one-way ANOVA). 
 
Materials and Methods 
Cell culture 
Human lung adenocarcinoma cells (A549), hu-
man nasopharyngeal carcinoma cells (KB), human 
glioblastoma cells (U87MG), human mammary car-
cinoma cells (MCF-7), and human breast adenocarci-
noma cells (MDA-MB-436, MDA-MB-468) were pur-
chased from the American Type Culture Collection 
(ATCC, Manassas, VA, USA), maintained in RPMI 
1640 (Welgene, Daegu, Korea) containing 10% fetal 
bovine serum (FBS; Welgene, Daegu, Korea) and 100 
µg/mL streptomycin and 100 U/mL penicillin 
(Welgene, Daegu, Korea) in a humidified 5% CO2 
atmosphere at 37 °C. 
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Western blot analysis 
A549 cells were seeded onto 100×20 mm cell 
culture plates at a density of 2×106 cells per plate in 10 
mL of media with no sugar or Ac4ManNAz (50 µM) 
(Invitrogen, Carlsbad, CA, USA). After incubation for 
3 days, the cells were washed twice with DPBS (pH 
7.4) and harvested from the plates with a cell scraper. 
They were pelleted by centrifugation at 3,000×g for 5 
min, and the cell pellets were resuspended in 500 µL 
of lysis buffer (1% SDS, 100 mM Tris-HCl, pH 7.4) 
containing protease inhibitor cocktail (Complete, 
EDTA-free, Roche, NSW, Australia) and lysed with a 
probe-type sonifier at 4 °C. Sonicated lysates were 
incubated at 4 °C for 30 min to further solubilize pro-
teins. The insoluble debris was removed by centrifu-
gation for 10 min at 3,000×g. Final soluble protein 
concentrations were determined by bicinchoninic acid 
protein assay (Pierce, Rockford, IL, USA) to be 5 
mg/mL. Then, 20 µL of the lysate (5 mg/mL protein) 
was incubated with phosphine-PEG3-biotin (2 µL, 5 
mM in DPBS) (Pierce) for 6 h at 37 oC. Loading buffer 
was added to each sample, and samples were loaded 
onto 10% SPS-PAGE gel after heating at 95 oC. Pro-
teins were transferred to Hybond P membrane 
(Amercham, St. Albans, UK), and the membrane was 
blocked with 5% bovine serum albumin in TBST (50 
mM Tris-HCl, 150 mM NaCl, 0.1% Tween 20, pH 7.4) 
for 2 h. The membrane was then incubated with 
streptavidin-horseradish peroxidase (diluted 1:2,000 
in TBST) (Pierce) overnight at 4 oC. The membrane 
was rinsed three times with TBST and developed by 
using ECL Western Blotting Substrate (Pierce). 
Cellular imaging to determine the generated 
azide groups 
A549 cells were seeded onto 35-mm 
glass-bottom dishes at a density of 3×104 cells in 2 mL 
of growth media with Ac4ManNAz (50 µM, final 
concentration). After incubation for 3 days, the cells 
were washed twice with DPBS (pH 7.4) and incubated 
with DBCO-Cy5 (20 µM, final concentration) (Click 
Chemistry Tools, Scottsdale, AZ, USA) for 1 h at 37 oC. 
Cells were then rinsed with DPBS (pH 7.4) and fixed 
with formaldehyde–glutaraldehyde combined fixa-
tive for 15 min at room temperature. After fixation, 
the cells were washed twice with DPBS (pH 7.4) and 
stained with DAPI (Invitrogen, Carlsbad, CA, USA) to 
label nuclei. All cellular images were obtained using a 
FluoView FV1000 confocal laser scanning microscope 
(Olympus, Tokyo, Japan) equipped with a 405 diode 
(405 nm) and HeNe-Red (633 nm) lasers. The same 
method was used in the case of KB, U87MG, MCF-7, 
MDA-MB-468, and MDA-MB-436 cells.  
To verify that a majority of the glycan signal 
remains localized to the A549 cells, N3-labeled cells 
were co-cultured with GFP-expressing A549 cells (non 
N3 labeled cells). Prior to co-culture, non 
GFP-expressing A549 cells were treated with 
Ac4ManNAz (50 µM, final concentration) to induce 
azide groups on the cell surface for 3 days. Then, 
GFP-expressing A549 cells were co-cultured with 
N3-labeled A549 cells for 1 day. After that, co-cultured 
cells were reacted with DBCO-Cy5 for cellular imag-
ing. 
The azide retention evaluation was performed 
for 3 days in vitro and in vivo. For retention evalua-
tion of the azide on the cell surface in vitro, 
N3-labelled cells were reacted immediately with 
DBCO-Cy5 before flow cytometry analysis and im-
aging at each time point (0, 1, and 3 day). To examine 
retention of azide groups for 3 days in vivo, 
N3-labeled cells were directly injected into the left lobe 
of the liver. Three days after injection, the liver was 
retrieved and embedded in OCT tissue compound for 
frozen section of liver tissue. Tissue sections were 
directly reacted with DBCO-Cy5 for 1 h at 37 oC. The 
section reacted with DBCO-Cy5 was washed three 
times with DPBS (pH 7.4). Fluorescence images were 
observed using IX81-ZDC focus drift compensating 
microscope (Olympus, Tokyo, Japan). 
Flow cytometry analysis to determine the 
generated azide groups 
A549 cells were seeded onto six-well plates at a 
density of 2×104 cells per well in 2 mL of media with 
Ac4ManNAz (50 µM final concentration) and treated 
with DBCO-Cy5, as described above. Cells were then 
lifted with DPBS (pH 7.4) containing 2% FBS and 1 
mM EDTA (FACS buffer) and washed twice in FACS 
buffer. Ten thousand cells per sample were analyzed 
by flow cytometry (BD FACSVerse; BD Biosciences, 
San Jose, CA, USA), and subsequent data analysis was 
done using FlowJo software (TreeStar, San Carlos, 
CA, USA). To prove a DBCO-Cy5 concentra-
tion-dependent labeling effect, various concentrations 
of DBCO-Cy5 (0 to 50 µM) were tested under similar 
conditions. A549 cells, fluorescently labeled according 
to the manufacturer’s protocol using DiD dye (Invi-
trogen) were used as controls. 
Cell viability assay 
To measure cell viability, A549 cells were seeded 
on 96-well plates (5×103 cells/well) and incubated for 
1 day. Cells were incubated with various concentra-
tions of Ac4MAnNAz or DBCO-Cy5 (0 to 100 µM) for 
3 days at 37 °C. Cell Counting Kit-8 solution (10 µL) 
(Dojindo Molecular Technologies Inc., Kumamoto, 
Japan) was then added to each well. After further in-
cubation for 2 h at 37 °C, the absorbance of each well 
was measured at 450 nm using a microplate reader 
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(VERSAmaxTM, Molecular Devices Corp., Sunnyvale, 
CA, USA). 
 To measure cell viability, A549 cells were seeded 
on 96-well plates (5×103 cells/well) and incubated 
with DBCO-Cy5 or DiD dye (0 to 50 µM) for 1 day. 
Afterwards, 25 µL of MTT in serum-free RPMI1640 
media (0.5 mg/mL) was added to each well. After 
incubation for 4 h at 37 °C, the media was removed 
and cells were dissolved in 200 µL of DMSO. Then, 
the absorbance of each well was measured at 560 nm 
using a microplate reader (VERSAmaxTM, Molecular 
Devices Corp., Sunnyvale, CA, USA). 
Flow cytometry analysis to examine labeling 
efficacy of genetic modification 
The GFP-encoding plasmid DNA (pCMV-EGFP) 
(Clontech Laboratories Inc., Palo Alto, CA, USA) 
complex with Lipo2k (Invitrogen) was prepared ac-
cording to the manufacturer’s protocol. BPEI (25 kDa) 
were prepared at the N/P ratio of 20/1. A549 cells 
were seeded onto six-well plates at a density of 5×105 
cells per well in 2 mL of serum-free media and grown 
to reach 60–80% confluence. The culture medium was 
replaced with 2 mL of the transfection medium con-
taining the Lipo2k or BPEI complex, followed by 6 h 
incubation at 37 °C. Then, the transfection medium 
was replaced with fresh complete RPMI 1640 (10% 
FBS), and the cells were allowed to grow for 48 h. Af-
ter incubation, the cells were washed twice with DPBS 
(pH 7.4), and flow cytometry analysis was performed 
by the same method as described above. 
Peritoneal macrophage isolation 
Peritoneal macrophages were isolated by peri-
toneal lavage with DPBS from 6-weak-old male 
athymic nude mice (20 g, Orient, Seoul, Korea). Con-
taminating erythrocytes, granulocytes, and dead cells 
were removed from the lavage media by density gra-
dient centrifugation for 20 min at 800×g. Purified per-
itoneal macrophages were washed three times and 
cultured in RPMI 1640 containing 10% FBS. 
Co-culture system to examine distorted 
signals  
Prior to co-culture, apoptosis of A549 
cell-acquired azide groups was induced by incubation 
with staurosporine at 5 µM for 24 h [34-36]. Peritoneal 
macrophages were seeded onto 35-mm glass-bottom 
dishes or six-well plates at a density of 1×106 cells in 2 
mL of media and incubated for 24 h. Macrophages 
were then incubated with apoptotic cells for up to 2 h 
at 37 °C. After incubation, macrophages were washed 
twice with DPBS (pH 7.4) and stained with 
FITC-F4/80 monoclonal antibody (Abcam, Cam-
bridge, UK). A549 cells, fluorescently labeled accord-
ing to the manufacturer’s protocol using DiD dye 
(Invitrogen) prior to the induction of apoptosis, were 
used as controls. Cellular imaging and flow cytometry 
analysis were performed by the same methods as de-
scribed above. 
In vivo/ex vivo imaging 
All experiments with live animals were per-
formed in compliance with the relevant laws and in-
stitutional guidelines of the Korea Institute of Science 
and Technology, and institutional committees ap-
proved the experiments. Six-week-old male, athymic, 
nude mice were anesthetized with ketamine (80 
mg/kg body weight) and xylazine (10 mg/kg body 
weight) by intraperitoneal injection, and laparotomy 
was performed with direct injection of A549 cells, 
after treatment with Ac4ManNAz for 3 days, into the 
left lobe of the liver. Three days post injection of cells 
into the liver, DBCO-Cy5 (25 µM, 200 µL) was injected 
by tail vein (n=3 per each group), and in vivo and ex 
vivo near-infrared fluorescence (NIRF) images were 
obtained with the IVIS-spectrum system (Perkin 
Elmer, Waltham, MA, USA) and KODAK Image Sta-
tion 4000 MM (KODAK , New Haven, CT, USA), re-
spectively.  
Intravital imaging of the liver tissue 
Intravital real-time images of liver tissues were 
obtained using an Olympus IV100 Intravital Laser 
Scanning Microscope (Olympus) equipped with an 
Argon laser (488 nm) and a red helium-neon 
(HeNe-Red) laser (633 nm). Immediately before the 
intravital liver imaging, the animal was anesthetized 
(2% isoflurane in 2 L/min O2). The liver tissue was 
exposed by making an incision in the skin at the liver 
site. This was followed by intravenous injection of 
FITC-labeled dextran (10 mg/kg) to visualize the liver 
vasculature and then DBCO-Cy5 (25 µM, 200 µL) to 
observe their traces in the target cell-acquired azide 
groups. 
Histological analysis 
The retrieved liver tissues were fixed in 4% 
(volume/volume) buffered paraformaldehyde solu-
tion and embedded in OCT tissue compound (Sakura, 
Tokyo, Japan). They were then frozen in a dry ice 
bath, cut on a cryostat (6 μm in thickness), picked up 
on slides with poly-D-lysine, and dried at 45 °C under 
light protection. Fluorescence images were obtained 
using a FluoView FV10i confocal scanning microscope 
(Olympus) equipped with a water-immersion objec-
tive lens (UplanSApo 60×/NA=1.2) and a diode laser. 
The excitation wavelength was 405 nm (17.1 mW) for 
the DAPI stain and 635 nm (9.5 mW) for the 
DBCO-Cy5. One day after injection of DBCO-Cy5, the 
organs of DBCO-Cy5-injected mice, including the 
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liver, lung, spleen, and kidneys were also harvested 
and examined histologically to determine cytotoxicity 
of DBCO-Cy5 to the distant organs. The sliced tissues 
(6 μm) were stained with hematoxylin and eosin and 
observed with a light microscope (BX51; Olympus). 
Images were photographed on a digital camera pho-
tomicroscope (DP71; Olympus). To examine distorted 
signals, the sliced liver tissues (6 μm) were stained 
with FITC-F4/80 monoclonal antibody (Abcam, 
Cambridge, UK). Fluorescence images were observed 
using IX81-ZDC focus drift compensating microscope 
(Olympus, Tokyo, Japan). 
Supplementary Material 
Figure S1. http://www.thno.org/v04p0420s1.pdf  
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